Cargando…

The Protective Effects of 2’-Fucosyllactose Against E. Coli O157 Infection Are Mediated by the Regulation of Gut Microbiota and the Inhibition of Pathogen Adhesion

As the richest component in human milk oligosaccharides (HMOs), 2’-fucosyllactose (2’-FL) can reduce the colonization of harmful microbiota in vivo, thus lowering the risk of infection; however, the mechanism for this is still unclear. In this study, a model of Escherichia coli O157 infection in hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuanyifei, Zou, Yan, Wang, Jin, Ma, Hui, Zhang, Bowei, Wang, Shuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282266/
https://www.ncbi.nlm.nih.gov/pubmed/32369957
http://dx.doi.org/10.3390/nu12051284
_version_ 1783544101562482688
author Wang, Yuanyifei
Zou, Yan
Wang, Jin
Ma, Hui
Zhang, Bowei
Wang, Shuo
author_facet Wang, Yuanyifei
Zou, Yan
Wang, Jin
Ma, Hui
Zhang, Bowei
Wang, Shuo
author_sort Wang, Yuanyifei
collection PubMed
description As the richest component in human milk oligosaccharides (HMOs), 2’-fucosyllactose (2’-FL) can reduce the colonization of harmful microbiota in vivo, thus lowering the risk of infection; however, the mechanism for this is still unclear. In this study, a model of Escherichia coli O157 infection in healthy adult mice was established to explore the effect of 2’-FL intervention on E. coli O157 colonization and its protective effects on mice. The results showed that 2’-FL intake reduced E. coli O157 colonization in mice intestine by more than 90% (p < 0.001), and it also reduced intestinal inflammation, increased the content of fecal short-chain fatty acids, and enhanced intestinal barrier function. These beneficial effects were attributed to the increased expression of mucins such as MUC2 (increased by more than 20%, p < 0.001), and inhibition of E. coli O157 cell adhesion (about 30% reduction, p < 0.001), and were associated with the modulation of gut microbiota composition. 2’-FL significantly increased the abundance of Akkermansia, a potential probiotic, which may represent the fundamental means by which 2’-FL enhances the expression of mucin and reduces the colonization of harmful bacteria. The current study may support the use of 2’-FL in the prevention of foodborne pathogen infections in human.
format Online
Article
Text
id pubmed-7282266
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72822662020-06-19 The Protective Effects of 2’-Fucosyllactose Against E. Coli O157 Infection Are Mediated by the Regulation of Gut Microbiota and the Inhibition of Pathogen Adhesion Wang, Yuanyifei Zou, Yan Wang, Jin Ma, Hui Zhang, Bowei Wang, Shuo Nutrients Article As the richest component in human milk oligosaccharides (HMOs), 2’-fucosyllactose (2’-FL) can reduce the colonization of harmful microbiota in vivo, thus lowering the risk of infection; however, the mechanism for this is still unclear. In this study, a model of Escherichia coli O157 infection in healthy adult mice was established to explore the effect of 2’-FL intervention on E. coli O157 colonization and its protective effects on mice. The results showed that 2’-FL intake reduced E. coli O157 colonization in mice intestine by more than 90% (p < 0.001), and it also reduced intestinal inflammation, increased the content of fecal short-chain fatty acids, and enhanced intestinal barrier function. These beneficial effects were attributed to the increased expression of mucins such as MUC2 (increased by more than 20%, p < 0.001), and inhibition of E. coli O157 cell adhesion (about 30% reduction, p < 0.001), and were associated with the modulation of gut microbiota composition. 2’-FL significantly increased the abundance of Akkermansia, a potential probiotic, which may represent the fundamental means by which 2’-FL enhances the expression of mucin and reduces the colonization of harmful bacteria. The current study may support the use of 2’-FL in the prevention of foodborne pathogen infections in human. MDPI 2020-05-01 /pmc/articles/PMC7282266/ /pubmed/32369957 http://dx.doi.org/10.3390/nu12051284 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wang, Yuanyifei
Zou, Yan
Wang, Jin
Ma, Hui
Zhang, Bowei
Wang, Shuo
The Protective Effects of 2’-Fucosyllactose Against E. Coli O157 Infection Are Mediated by the Regulation of Gut Microbiota and the Inhibition of Pathogen Adhesion
title The Protective Effects of 2’-Fucosyllactose Against E. Coli O157 Infection Are Mediated by the Regulation of Gut Microbiota and the Inhibition of Pathogen Adhesion
title_full The Protective Effects of 2’-Fucosyllactose Against E. Coli O157 Infection Are Mediated by the Regulation of Gut Microbiota and the Inhibition of Pathogen Adhesion
title_fullStr The Protective Effects of 2’-Fucosyllactose Against E. Coli O157 Infection Are Mediated by the Regulation of Gut Microbiota and the Inhibition of Pathogen Adhesion
title_full_unstemmed The Protective Effects of 2’-Fucosyllactose Against E. Coli O157 Infection Are Mediated by the Regulation of Gut Microbiota and the Inhibition of Pathogen Adhesion
title_short The Protective Effects of 2’-Fucosyllactose Against E. Coli O157 Infection Are Mediated by the Regulation of Gut Microbiota and the Inhibition of Pathogen Adhesion
title_sort protective effects of 2’-fucosyllactose against e. coli o157 infection are mediated by the regulation of gut microbiota and the inhibition of pathogen adhesion
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282266/
https://www.ncbi.nlm.nih.gov/pubmed/32369957
http://dx.doi.org/10.3390/nu12051284
work_keys_str_mv AT wangyuanyifei theprotectiveeffectsof2fucosyllactoseagainstecolio157infectionaremediatedbytheregulationofgutmicrobiotaandtheinhibitionofpathogenadhesion
AT zouyan theprotectiveeffectsof2fucosyllactoseagainstecolio157infectionaremediatedbytheregulationofgutmicrobiotaandtheinhibitionofpathogenadhesion
AT wangjin theprotectiveeffectsof2fucosyllactoseagainstecolio157infectionaremediatedbytheregulationofgutmicrobiotaandtheinhibitionofpathogenadhesion
AT mahui theprotectiveeffectsof2fucosyllactoseagainstecolio157infectionaremediatedbytheregulationofgutmicrobiotaandtheinhibitionofpathogenadhesion
AT zhangbowei theprotectiveeffectsof2fucosyllactoseagainstecolio157infectionaremediatedbytheregulationofgutmicrobiotaandtheinhibitionofpathogenadhesion
AT wangshuo theprotectiveeffectsof2fucosyllactoseagainstecolio157infectionaremediatedbytheregulationofgutmicrobiotaandtheinhibitionofpathogenadhesion
AT wangyuanyifei protectiveeffectsof2fucosyllactoseagainstecolio157infectionaremediatedbytheregulationofgutmicrobiotaandtheinhibitionofpathogenadhesion
AT zouyan protectiveeffectsof2fucosyllactoseagainstecolio157infectionaremediatedbytheregulationofgutmicrobiotaandtheinhibitionofpathogenadhesion
AT wangjin protectiveeffectsof2fucosyllactoseagainstecolio157infectionaremediatedbytheregulationofgutmicrobiotaandtheinhibitionofpathogenadhesion
AT mahui protectiveeffectsof2fucosyllactoseagainstecolio157infectionaremediatedbytheregulationofgutmicrobiotaandtheinhibitionofpathogenadhesion
AT zhangbowei protectiveeffectsof2fucosyllactoseagainstecolio157infectionaremediatedbytheregulationofgutmicrobiotaandtheinhibitionofpathogenadhesion
AT wangshuo protectiveeffectsof2fucosyllactoseagainstecolio157infectionaremediatedbytheregulationofgutmicrobiotaandtheinhibitionofpathogenadhesion